Abstract
Noninfectious lung diseases contribute to nonrelapse mortality. They constitute a spectrum of diseases that can affect the parenchyma, airways, or vascular pulmonary components and specifically exclude cardiac and renal causes. The differential diagnoses of these entities differ as a function of time after hematopoietic cell transplantation. Specific diagnosis, prognosis, and optimal treatment remain challenging, although progress has been made in recent decades.
Copyright © 2021 by The American Society of Hematology.
MeSH terms
-
Child
-
Cytokine Release Syndrome / diagnosis
-
Cytokine Release Syndrome / etiology
-
Cytokine Release Syndrome / mortality
-
Cytokine Release Syndrome / therapy
-
Disease Management
-
Female
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Hematopoietic Stem Cell Transplantation / mortality
-
Hemorrhage / diagnosis
-
Hemorrhage / etiology
-
Hemorrhage / mortality
-
Hemorrhage / therapy
-
Humans
-
Infant
-
Lung Diseases / diagnosis
-
Lung Diseases / etiology*
-
Lung Diseases / mortality
-
Lung Diseases / therapy
-
Male
-
Risk Factors
-
Thrombotic Microangiopathies / diagnosis
-
Thrombotic Microangiopathies / etiology
-
Thrombotic Microangiopathies / mortality
-
Thrombotic Microangiopathies / therapy